150 related articles for article (PubMed ID: 2909993)
1. Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
Colucci WS
Am J Cardiol; 1989 Jan; 63(2):17A-22A. PubMed ID: 2909993
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
Colucci WS; Denniss AR; Leatherman GF; Quigg RJ; Ludmer PL; Marsh JD; Gauthier DF
J Clin Invest; 1988 Apr; 81(4):1103-10. PubMed ID: 2832444
[TBL] [Abstract][Full Text] [Related]
3. Myocardial and vascular actions of milrinone.
Colucci WS
Eur Heart J; 1989 Aug; 10 Suppl C():32-8. PubMed ID: 2680495
[TBL] [Abstract][Full Text] [Related]
4. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
5. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
[TBL] [Abstract][Full Text] [Related]
6. Role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failure.
Arnold JM; Ludmer PL; Wright RF; Ganz P; Braunwald E; Colucci WS
J Am Coll Cardiol; 1986 Aug; 8(2):413-8. PubMed ID: 3734263
[TBL] [Abstract][Full Text] [Related]
7. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
[TBL] [Abstract][Full Text] [Related]
9. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
Liang CS; Thomas A; Imai N; Stone CK; Kawashima S; Hood WB
J Cardiovasc Pharmacol; 1987 Nov; 10(5):509-16. PubMed ID: 2447398
[TBL] [Abstract][Full Text] [Related]
10. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
Grose R; Strain J; Greenberg M; LeJemtel TH
J Am Coll Cardiol; 1986 May; 7(5):1107-13. PubMed ID: 3958369
[TBL] [Abstract][Full Text] [Related]
11. [Additive effects of milrinone and dobutamine in severe heart failure].
Meissner A; Herrmann G; Gerdesmeyer L; Simon R
Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
[TBL] [Abstract][Full Text] [Related]
12. Modulation of venous tone in heart failure.
Muir AL; Nolan J
Am Heart J; 1991 Jun; 121(6 Pt 2):1948-50. PubMed ID: 2035425
[TBL] [Abstract][Full Text] [Related]
13. Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.
Mehra MR; Ventura HO; Kapoor C; Stapleton DD; Zimmerman D; Smart FW
Am J Cardiol; 1997 Jul; 80(1):61-4. PubMed ID: 9205021
[TBL] [Abstract][Full Text] [Related]
14. Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
Gosgnach M; Gérard JL; Berdeaux A; Giudicelli JF
Fundam Clin Pharmacol; 1991; 5(8):709-18. PubMed ID: 1783360
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion.
Colucci WS; Leatherman GF; Ludmer PL; Gauthier DF
Circ Res; 1987 Oct; 61(4 Pt 2):I82-6. PubMed ID: 3652407
[TBL] [Abstract][Full Text] [Related]
16. In vivo studies of myocardial beta-adrenergic receptor pharmacology in patients with congestive heart failure.
Colucci WS
Circulation; 1990 Aug; 82(2 Suppl):I44-51. PubMed ID: 2164896
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of milrinone.
Colucci WS
Am Heart J; 1991 Jun; 121(6 Pt 2):1945-7. PubMed ID: 2035424
[TBL] [Abstract][Full Text] [Related]
18. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.
Cody RJ; Müller FB; Kubo SH; Rutman H; Leonard D
Circulation; 1986 Jan; 73(1):124-9. PubMed ID: 3940663
[TBL] [Abstract][Full Text] [Related]
19. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R
Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
[TBL] [Abstract][Full Text] [Related]
20. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
Mager G; Klocke RK; Volkmann A; Kux A; Höpp HW; Hilger HH
Z Kardiol; 1991 Feb; 80(2):149-57. PubMed ID: 2058247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
